Atlas Trials

Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy

Clinical trial NCT07119775 · AVAILABLE

Trial details

NCT number
NCT07119775
Sponsor
AMO Pharma Limited
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Congenital Myotonic Dystrophy

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.